Yahoo
NasdaqGS - Delayed Quote USD

AgomAb Therapeutics NV (AGMB)

7.49 -0.46 (-5.79%)
At close: October 30 at 4:00:01 PM EDT
Trade AGMB on Coinbase
View in AlphaSpace Currency in EUR All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
65,942
59,275
48,021
31,190
22,634
Operating Income
-65,942
-59,275
-48,021
-31,190
-22,634
Net Non Operating Interest Income Expense
4,292
1,546
1,141
210
25
Other Income Expense
-5,000
-4,818
617
18,971
11,803
Pretax Income
-66,650
-62,547
-46,263
-12,009
-10,806
Tax Provision
0
0
4
-619
-2,664
Net Income Common Stockholders
-66,650
-62,547
-46,267
-11,390
-8,142
Diluted NI Available to Com Stockholders
-66,650
-62,547
-46,267
-11,390
-8,142
Basic EPS
-1.35
-1.28
-1.28
-0.31
-0.22
Diluted EPS
-1.35
-1.28
-1.28
-0.31
-0.22
Basic Average Shares
49,247.98
48,736.78
36,236.78
36,236.78
36,236.78
Diluted Average Shares
49,247.98
48,736.78
36,236.78
36,236.78
36,236.78
Total Operating Income as Reported
-65,941
-59,275
-48,021
-31,190
-22,634
Rent Expense Supplemental
--
211
137
178
122
Total Expenses
65,942
59,275
48,021
31,190
22,634
Net Income from Continuing & Discontinued Operation
-66,650
-62,547
-46,267
-11,390
-8,142
Normalized Income
-66,689
-62,586
-46,093.75
-11,396.65
-8,089.54
Interest Income
4,495
1,609
1,218
245
71
Interest Expense
200
60
67
31
45
Net Interest Income
4,292
1,546
1,141
210
25
EBIT
-66,450
-62,487
-46,196
-11,978
-10,761
EBITDA
-66,253
-62,268
-45,885
-11,879
-10,738
Reconciled Depreciation
197
219
311
99
23
Net Income from Continuing Operation Net Minority Interest
-66,650
-62,547
-46,267
-11,390
-8,142
Total Unusual Items Excluding Goodwill
39
39
-231
7
-86
Total Unusual Items
39
39
-231
7
-86
Normalized EBITDA
-66,292
-62,307
-45,654
-11,886
-10,652
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
-57.75
0.35
-33.54
12/31/2022 - 2/6/2026

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: